The Enterprise Value as of September 2024 (TTM) for Reneo Pharmaceuticals, Inc. (RPHM) is 10.65M

According to Reneo Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 10.65M. This represents a change of -87.00% compared to the average of 81.92M of the last 4 quarters.

Reneo Pharmaceuticals, Inc. (RPHM) Historical Enterprise Value (quarterly & annually)

How has RPHM Enterprise Value performed in the past?

The mean historical Enterprise Value of Reneo Pharmaceuticals, Inc. over the last ten years is 106.46M. The current 10.65M Enterprise Value has changed 900.44% with respect to the historical average. Over the past ten years (40 quarters), RPHM's Enterprise Value was at its highest in in the March 2021 quarter at 412.02M. The Enterprise Value was at its lowest in in the June 2022 quarter at -51965866.40.

Reneo Pharmaceuticals, Inc. (RPHM) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Reneo Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Reneo Pharmaceuticals, Inc. (RPHM) Average Enterprise Value

How has RPHM Enterprise Value performed in the past?

The current Enterprise Value of Reneo Pharmaceuticals, Inc. (RPHM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Reneo Pharmaceuticals, Inc. (RPHM) Enterprise Value vs. Peers

How is RPHM’s Enterprise Value compared to its peers?

Reneo Pharmaceuticals, Inc.’s Enterprise Value is less than Prime Medicine, Inc. (434.90M), less than Ginkgo Bioworks Holdings, Inc. (65.78M), less than Ocean Biomedical, Inc. (45.32M), less than Royalty Pharma plc (18.50B), less than Immix Biopharma, Inc. (27.90M), greater than CNS Pharmaceuticals, Inc. (3.51M), greater than Hepion Pharmaceuticals, Inc. (1.98M), greater than Freeline Therapeutics Holdings plc (2.82M), greater than AVROBIO, Inc. (-85302404.00), less than Summit Therapeutics Inc. (21.43B), less than Nkarta, Inc. (363.83M), less than Cullinan Oncology, Inc. (869.26M), less than Kezar Life Sciences, Inc. (31.14M), less than Kronos Bio, Inc. (14.32M), less than Adaptive Biotechnologies Corporation (843.33M), less than Legend Biotech Corporation (9.53B), less than Vir Biotechnology, Inc. (879.06M), less than Apellis Pharmaceuticals, Inc. (4.53B), greater than Werewolf Therapeutics, Inc. (-5104292.00), less than Edgewise Therapeutics, Inc. (1.54B), less than Decibel Therapeutics, Inc. (96.42M), less than Celcuity Inc. (626.69M), less than C4 Therapeutics, Inc. (436.29M),

Build a custom stock screener for Reneo Pharmaceuticals, Inc. (RPHM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Reneo Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Reneo Pharmaceuticals, Inc. (RPHM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Reneo Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.